Aditxt (ADTX) Beginning Cash Balance (2023 - 2024)

Aditxt (ADTX) recorded quarterly Beginning Cash Balance of $375000.0 in Q1 2024, up 25.0% quarter-over-quarter from $300000.0 in Q3 2023.

Aditxt (ADTX) Beginning Cash Balance (2023 - 2024) Analysis & Trends

Aditxt's Beginning Cash Balance history runs 2 years deep, the most recent figure standing at $375000.0 for Q1 2024.

In Q1 2024, Beginning Cash Balance changed N/A year-over-year to $375000.0; the TTM figure through Jun 2024 stood at $675000.0 (changed N/A YoY), while the FY2023 annual figure was $687523.0, up 759.4% from the prior year.
Beginning Cash Balance was $375000.0 for Q1 2024 at Aditxt, up from $300000.0 in the prior quarter.
In the past five years, Beginning Cash Balance ranged from a high of $375000.0 in Q1 2024 to a low of $300000.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Aditxt	2,485.68	-2.16 Mn	2,868.00

Download Data